Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
@inproceedings{Hossain2018HumanAM,
title={Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions},
author={Liakat Hossain and Md. Arifuzzaman and Farzana Diba and Ayesha Siddika and M. H. Adnan and Naznin Akhtar and Md.Zahid Hasan and Sikder M. Asaduzzaman},
year={2018}
}The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of…
References
SHOWING 1-10 OF 90 REFERENCES
Amniotic membrane transplantation in the human eye.
- MedicineDeutsches Arzteblatt international
- 2011
AMT is an established technique in the treatment of various diseases of the external eye and has brought about major advances in the reconstructive surgery of the ocular surface in the last few years.
Human amniotic membrane transplantation: Different modalities of its use in ophthalmology.
- MedicineWorld journal of transplantation
- 2014
The amniotic membrane is being used increasingly for ocular surface reconstruction in a variety of ocular pathologies including corneal disorders associated with limbal stem cell deficiency, surgeries for conjunctival reconstruction, as a carrier for ex vivo expansion of limbal epithelial cells, glaucoma surgeries and sceral melts and perforations.
Amniotic membrane extract and eye drops: a review of literature and clinical application
- MedicineClinical ophthalmology
- 2018
An overview on the recent progress in the preparation, mechanisms of action, and use of AM extract/AM extract eye drops for corneal and external eye diseases is provided.
[Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
- MedicineJournal francais d'ophtalmologie
- 2001
Amniotic membrane use in the treatment of ocular surface pathology as an adjunct to stem cell grafts of the corneal limbus and its ability to modulate stromal scarring and its anti-inflammatory and anti-bacterial activity are reported.
Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders.
- MedicineIndian journal of ophthalmology
- 2007
The current literature on the applications of amniotic membrane transplantation and its outcome in various ophthalmic conditions is reviewed.
Amniotic Membrane Transplantation
- Medicine
- 2007
The basic structure and properties of amniotic membrane, its preparation process and its applications in ophthalmology are described.
Amniotic membrane transplantation: An option for ocular surface disorders
- MedicineOman journal of ophthalmology
- 2011
AMT in various ocular surface pathologies shows success in achieving the goal of symptomatic relief, improved epithelialization, stromal healing and vision.
Antiinflammatory Effects of Amniotic Membrane Transplantation in Ocular Surface Disorders
- Medicine, BiologyCornea
- 2001
Amniotic membrane attracts and traps inflammatory cells infiltrating the ocular surface, which may explain some of the antiinflammatory properties of the fetal tissue.
Amniotic membrane transplantation for ocular surface reconstruction
- MedicineThe British journal of ophthalmology
- 1999
AMT was effective to promote corneal healing in patients with persistent epithelial defect, and appeared to be helpful after surgery to release corneo-conjunctival adhesion.
The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas.
- MedicineKorean journal of ophthalmology : KJO
- 1995
Human amniotic membrane isolated from the placenta contained basement membrane components such as type IV collagen, laminin, and 6 and 4 integrins, all of which remained detectable while preserved in glycerin for one week, and it was concluded that the success correlated with the return of a cornea-like epithelial phenotype and the preservation of the amniotics.




